State to Recover Medicaid Money from Maker of Claritin
OLYMPIA -- Pharmaceutical manufacturer Schering Plough will reimburse Washington's Medicaid program $3.57 million in a nationwide settlement of allegations the drug maker failed to offer state Medicaid programs its best price for the popular antihistamine drug Claritin.
Under the settlement, Schering will reimburse overcharges totaling $140.7 million to Medicaid programs in 49 states and the District of Columbia. The states' settlement was reached in conjunction with a federal settlement also filed today in U.S. District Court in Philadelphia.